Proteome Sciences plc (PMSNF) Research

Proteome Sciences plc specializes in providing expert contract research services focused on the identification, validation, and practical application of protein biomarkers. The company operates globally, serving clients across the United States, the United Kingdom, and the European Union. Among their key analytical solutions is SysQuant, which offers comprehensive insights into protein activity across vital regulatory and signaling pathways. They also feature TMT MS2 for efficiently analyzing cells and tissues without the need for phosphopeptide enrichment, and TMT MS3, a method paramount for precise biomarker discovery in complex samples like plasma. Their offerings further extend to TMT Calibrator, enabling the simultaneous analysis of diseased or treated tissue alongside peripheral fluids. For the rapid validation of potential biomarker candidates, they utilize TMT SRM, a targeted assay format. Additionally, Proteome Sciences provides a dedicated SRM assay, a targeted mass spectrometry technique for the routine quantification of biomarkers. Complementing these services, the company develops a suite of bioinformatics tools. This includes Proteome Discoverer, used for peptide sequencing and TMT quantification; SQuaT, CalDIT, and DIANA, which normalize quantitative data and provide functional annotation at both peptide and protein levels; FeaST, designed for visualizing data quality, constructing class identifier models, and generating lists of biomarker candidates; and FAT, employed to identify variances within biological processes and cellular components. Proteome Sciences primarily caters to pharmaceutical and biotechnology firms, as well as academic research institutions. Founded in 1993, the company's headquarters are located in Cobham, United Kingdom.

Open Proteome Sciences plc (PMSNF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.